Hi, what are you looking for?
Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, ended the year on a really high note...
NeuroDerm, an Israeli clinical-stage pharmaceutical company, announced that patients with moderate to severe Parkinson’s disease who received continuous, subcutaneous doses of liquid levodopa/carbidopa (LD/CD)...
– Intec Pharma says it expects the Phase III trial for its Accordion Pill Levodopa to take place in the second half of 2015....
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled a batch of its generic Parkinson’s combination drug treatment carbidopa/levodopa because of concern that...
Israel’s NeuroDerm Ltd., announced that it raised $16 million to further the clinical and regulatory development of its Levodopa products, combating Parkinson’s disease. ND0612L, NeuroDerm’s...
– New Tel Aviv University study confirms creative energy in Parkinson’s sufferers is greater than in healthy individuals. Prof. Rivka Inzelberg of...
– Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan. – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company...
– – Brainsway Ltd. (TASE:BRIN) today reported success in a clinical trial on Parkinson’s disease. The company reported the final results of a double-blind clinical...
– Neurosurgeon in Celebration, Fla. Performs World’s First Deep Brain Stimulation using Mazor Robotics Renaissance to Treat Parkinson’s Disease. Renaissance is currently being used in...
New step length monitoring method 4x more accurate than standard biomechanical models